Investors & Partners
Working together to accelerate drug development and bring new treatments to patients.
Investors
Angel Investors
Private investors supporting OrchestratePharma's early development programs and drug repurposing pipeline.
Partners
Cellix Biosciences
Collaboration partner for Chronic Spontaneous Urticaria (CSU) development — agreement signed November 2021.
IVRS
Indian Contract Research Organisation — clinical trial partner for the Phase 1 bioavailability study of OP2101.
Become a Partner
We are actively seeking investors, research partners, and clinical collaborators to help advance our pipeline.
Contact Us